Aug 9 (Reuters) - Gossamer Bio Inc GOSS.O :
* GOSSAMER BIO ANNOUNCES SECOND QUARTER 2022 FINANCIAL RESULTS AND PROVIDES
BUSINESS UPDATE
* $342 MILLION IN CASH, CASH EQUIVALENTS & MARKETABLE SECURITIES, AS OF JUNE
30,
2022
* GOSSAMER BIO - EXPECTS COMBINATION OF CURRENT CASH, CASH EQUIVALENTS
SUFFICIENT
TO FUND ITS OPERATING AND CAPITAL EXPENDITURES INTO Q2 OF 2024
* NET LOSS FOR QUARTER ENDED JUNE 30, 2022, WAS $56.5 MILLION, OR $0.74 PER
SHARE
* Q2 EARNINGS PER SHARE VIEW $-0.70 -- REFINITIV IBES DATA
Source text for Eikon: ID:nBw5pTQlfa
Further company coverage: GOSS.O
((Reuters.Briefs@thomsonreuters.com;))